Clinical Trials Browser

Active not recruiting × OTHER × Paraganglioma × Clear all

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT03839498 2026-03-02

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

Phase 2 Active not recruiting

6 enrolled

CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT03946527 2026-03-02

LAMPARA

Phase 2 Active not recruiting

10 enrolled

CNSEndocrine

Paraganglioma, Pheochromocytoma

NCT02721732 2026-01-29

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Phase 2 Active not recruiting

157 enrolled 26 charts

CNSEndocrineGenitourinary

Adrenal Cortex Neoplasms, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms, Unknown Primary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Carcinoma, Small Cell, Vascular Neoplasms

NCT05233878 2025-06-30

PRONO-PARAG

Active not recruiting

25 enrolled

CNSEndocrine

Paraganglioma

Clinical Trials

DOTATOC PET/CT for Imaging NET Patients

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

LAMPARA

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

PRONO-PARAG